Advanced Accelerator Applications S.A. announced that its product NETSPOT (gallium Ga-68 dotatate) has been included in the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology version 1.2017 update for the evaluation of neuroendocrine tumors (NETs).

Results from a prospective clinical trial showed a blood test looking at specific biomarkers was able to detect lung cancer recurrences an average of six months before conventional imaging methods found evidence of recurrence. In the largest prospective clinical trial to date of circulating tumor cells (CTC) as biomarkers for locally advanced lung cancer, the findings indicate that blood tests potentially can be used in conjunction with computed tomography (CT) and positron emission tomography (PET)/CT scans to guide personalized treatment planning for patients with non-small cell lung cancer (NSCLC). The study was presented at the 2017 Multidisciplinary Thoracic Cancers Symposium, March 16-18 in San Diego.

March 28, 2017 — Young rabbits exposed to ultrasound during fetal development had weaker thighbones than unexposed rabbits, according to a study published in the Pertanika Journal of Science & Technology.

March 27, 2017 — iCAD announced that PowerLook Tomo Detection received Premarket Approval (PMA) from the U.S. Food and Drug Administration (FDA). PowerLook Tomo Detection is a concurrent-read computer-aided detection (CAD) solution for digital breast 3-D tomosynthesis, available on the PowerLook Breast Health Solutions platform. 

March 27, 2017 — Bracco Diagnostics Inc. announced the launch of its PROTOCO2L TOUCH Colon Insufflator. This device is used to inflate the colon with CO2 in patients who undergo computed tomography colonography (CTC) for the detection of colon cancer.

March 27, 2017 — Radiation therapists and physicians know that education can reduce anxiety before radiation treatment but lack a standardized tool. In an effort to solve this problem, a multidisciplinary team from Jefferson College of Health Professions and Sidney Kimmel Cancer Center at Thomas Jefferson University conducted a pilot study to see if a virtual environment education program could reduce some of the anxiety their patients face.

A new study offers hope for patients with recurrent lung cancer, who historically have been considered ineligible for curative treatment. In the largest analysis to date of re-irradiation using intensity-modulated proton therapy (IMPT) for lung and other thoracic tumors, more than three-fourths of patients were free from local recurrence at one year following retreatment, and fewer than one in ten patients experienced severe side effects. The study was presented at the 2017 Multidisciplinary Thoracic Cancers Symposium, March 14-16 in San Diego.

Medsquare announced the integration of the organ dose module VirtualDose CT into its DACS (dose archive and communication system) Radiation Dose Monitor (RDM) solution. Developed in partnership with Virtual Phantoms Inc., this new module will be added to RDM’s existing features. It was presented for the first time at the European Congress of Radiology (ECR), March 1-5 in Vienna, Austria.

March 24, 2017 — Facing the reality of not having enough votes to secure its passage, House leadership withdrew the American Health Care Act (AHCA) from consideration one hour before the final vote was scheduled to begin. House Speaker Paul Ryan (R-Wis.) withdrew the bill on a directive from President Donald Trump, according to the Associated Press, after both men were unable to negotiate a compromise between ultra-conservative and moderate elements within the Republican Party.

Subscribe Now